As with most cancers, survival for leukaemia is improving. Some of the increase is likely to be attributable to changes in the diagnosis, classification and registration of leukaemia, so interpretation of these trends should be undertaken with caution.
One-year
Leukaemia (C91-C95), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five-year age-standardised net survival for leukaemia in men has increased from 13% during 1971-1972 to a predicted survival of 54% during 2010-2011 in England and Wales – an absolute survival difference of 41 percentage points.[1] In women, five-year survival has increased from 13% to 49% over the same time period (a difference of 36 percentage points).
Leukaemia (C91-C95), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five-year survival for 2010-2011 is predicted using an excess hazard statistical model
Ten-year survival has followed the same trend as one- and five-year survival since the early 1970s. Ten-year age-standardised net survival for leukaemia in men has increased from 7% during 1971-1972 to a predicted survival of 48% during 2010-2011 in England and Wales – an absolute survival difference of 41 percentage points.[1] In women, ten-year survival has increased from 7% to 44% over the same time period (a difference of 37 percentage points). Overall, more than 4 in 10 people diagnosed with leukaemia today are predicted to survive their disease for at least ten years.
Leukaemia (C91-C95), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model
About this data
Data is for: England and Wales, 1971-2011, ICD-10 C91-C95